San Francisco company generates 300 human antibodies that bind the SARS-CoV2 virus

San Francisco based biotechnology company, Prellis Biologics, Inc. announced this week that it has generated 300 human IgG antibodies that bind to either the S1 or S2 spike protein of the SARS-CoV2-Wuhan strain of the novel coronavirus. Using the Prellis Externalized Human Immune SystemTM technology, the team produced 960 synthetic human lymph nodes that were challenged [...]

The post San Francisco company generates 300 human antibodies that bind the SARS-CoV2 virus appeared first on Outbreak News Today.